Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 dose-escalation and safety study of CP-461 in patients with Chronic Lymphocytic Leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 pilot study of OSI-461 in patients with chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients [Phase 1]
This Phase 1 study evaluated the safety and tolerability of an oral capsule form of PCI-24781 in adults with advanced cancers, and the trial…
-
CLINICAL_TRIALS research · 2011-09-14Clinical Trial Update: Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia [NA]
Clinical trial update examining natural killer cell function in patients with Chronic Lymphocytic Leukemia.
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease [Phase 2]
Phase 2 clinical trial evaluating a dasatinib-based combination in patients with refractory chronic lymphocytic leukemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL [Phase 1, Phase 2]
A Phase 1/2 study evaluating oxaliplatin, fludarabine, cytarabine, and rituximab in Richter's syndrome and refractory chronic lymphocytic le…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL) [Phase 2, Phase 3]
This clinical trial update reports the completion of a Phase 2/Phase 3 study comparing bendamustine to fludarabine in chronic lymphocytic le…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients [Phase 3]
Phase 3 trial comparing fludarabine plus alemtuzumab versus fludarabine alone in chronic lymphocytic leukemia; results completed and posted …
-
CLINICAL_TRIALS withdrawal · 2011-07-20Clinical Trial Update: PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab [Phase 2]
Phase 2 trial evaluating the combination of bendamustine and ofatumumab in relapsed/refractory chronic lymphocytic leukemia has been withdra…
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating valproic acid, an HDAC inhibitor, for chronic lymphocytic leukemia was terminated. The study status indicates the t…
-
CLINICAL_TRIALS other · 2011-07-20Clinical Trial Update: Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab [Phase 2]
Clinical trial protocol update for previously untreated chronic lymphocytic leukemia using bendamustine and ofatumumab; the trial status is …
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas [Phase 1, Phase 2]
Clinical trial update for a Phase 1-2 open-label study of AEG35156 in relapsed or refractory chronic lymphocytic leukemia and indolent B-cel…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies [Phase 2]
Phase II study assessing AT-101 as a single-agent therapy in relapsed or refractory B-cell malignancies has completed, reporting safety and …
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia [Phase 2]
This clinical trial update reports a Phase 2 study evaluating epoetin alfa for treating anemia caused by chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy with rituximab in patients with chronic lymphocytic leukemia or lymphocytic lymphom…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients [Phase 1, Phase 2]
Open-label, dose-escalation study evaluating the safety and tolerability of Acadesine in patients with chronic lymphocytic leukemia (B-CLL) …
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide for relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma …
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Alemtuzumab + Rituximab Consolidation in CLL [Phase 2]
Phase 2 clinical trial evaluating consolidation with alemtuzumab and rituximab in chronic lymphocytic leukemia has been terminated, with res…
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) [Phase 2]
This document reports a Phase 2 clinical trial of lenalidomide (Revlimid) in chronic lymphocytic leukemia, with the study completed and resu…
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia [Phase 3]
Phase 3 trial in previously untreated chronic lymphocytic leukemia compares fludarabine and cyclophosphamide with or without rituximab; resu…
-
CLINICAL_TRIALS research · 2011-02-28Clinical Trial Update: Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
KineMed reports the completion of a trial evaluating a kinetic biomarker for prognosis in chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders [Phase 2]
Phase 2 clinical trial evaluating the combination of Campath-1H (alemtuzumab) and rituximab for CD52- and CD20-positive refractory or relaps…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on using a conditioning regimen of fludarabine and melphalan for patients with chronic lymphocytic leukemia, l…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: SPC2996 in Chronic Lymphocytic Leukaemia [Phase 1, Phase 2]
Clinical trial update reporting completion of a Phase 1/2 study of SPC2996 in chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2011-01-13Clinical Trial Update: Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL) [Phase 2]
Phase 2 trial of alemtuzumab combined with fludarabine in relapsed/refractory B-cell chronic lymphocytic leukemia completed with posted resu…